AQR Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $170M | Sell |
2,387,964
-226,994
| -9% | -$17.5M | 0.08% | 346 |
|
|
2025
Q4 | $208M | Sell |
2,614,958
-437,881
| -14% | -$34.5M | 0.11% | 248 |
|
|
2025
Q3 | $230M | Buy |
3,052,839
+774,032
| +34% | +$53M | 0.15% | 180 |
|
|
2025
Q2 | $156M | Sell |
2,278,807
-1,408,461
| -38% | -$92.4M | 0.13% | 218 |
|
|
2025
Q1 | $249M | Buy |
3,687,268
+1,020,094
| +38% | +$61M | 0.26% | 83 |
|
|
2024
Q4 | $119M | Sell |
2,667,174
-1,386,324
| -34% | -$77.8M | 0.15% | 172 |
|
|
2024
Q3 | $255M | Sell |
4,053,498
-1,236,290
| -23% | -$72.1M | 0.35% | 45 |
|
|
2024
Q2 | $311M | Buy |
5,289,788
+1,327,855
| +34% | +$83.1M | 0.48% | 24 |
|
|
2024
Q1 | $315M | Sell |
3,961,933
-448,718
| -10% | -$34.3M | 0.54% | 22 |
|
|
2023
Q4 | $348M | Buy |
4,410,651
+10,521
| +0.2% | +$749K | 0.66% | 15 |
|
|
2023
Q3 | $307M | Sell |
4,400,130
-554,870
| -11% | -$39.3M | 0.63% | 17 |
|
|
2023
Q2 | $341M | Buy |
4,955,000
+247,852
| +5% | +$17.6M | 0.73% | 11 |
|
|
2023
Q1 | $350M | Buy |
4,707,148
+456,802
| +11% | +$38.3M | 0.77% | 10 |
|
|
2022
Q4 | $396M | Buy |
4,250,346
+415,961
| +11% | +$40.1M | 0.9% | 8 |
|
|
2022
Q3 | $366M | Buy |
3,834,385
+460,004
| +14% | +$45.5M | 0.89% | 9 |
|
|
2022
Q2 | $313M | Buy |
3,374,381
+2,000,311
| +146% | +$195M | 0.71% | 16 |
|
|
2022
Q1 | $139M | Buy |
1,374,070
+105,598
| +8% | +$11.1M | 0.26% | 77 |
|
|
2021
Q4 | $131M | Buy |
1,268,472
+387,664
| +44% | +$35.8M | 0.24% | 100 |
|
|
2021
Q3 | $74.7M | Sell |
880,808
-88,117
| -9% | -$7.38M | 0.14% | 174 |
|
|
2021
Q2 | $80.6M | Sell |
968,925
-63,526
| -6% | -$5.2M | 0.14% | 171 |
|
|
2021
Q1 | $77.7M | Sell |
1,032,451
-863,630
| -46% | -$62.9M | 0.13% | 187 |
|
|
2020
Q4 | $128M | Sell |
1,896,081
-1,064,752
| -36% | -$69.3M | 0.23% | 105 |
|
|
2020
Q3 | $172M | Sell |
2,960,833
-449,204
| -13% | -$28M | 0.29% | 72 |
|
|
2020
Q2 | $219M | Buy |
3,410,037
+2,549,974
| +296% | +$161M | 0.35% | 59 |
|
|
2020
Q1 | $51M | Buy |
860,063
+494,266
| +135% | +$33M | 0.09% | 266 |
|
|
2019
Q4 | $27M | Buy |
365,797
+289,344
| +378% | +$20.3M | 0.03% | 517 |
|
|
2019
Q3 | $4.82M | Sell |
76,453
-136,377
| -64% | -$8.08M | 0.01% | 988 |
|
|
2019
Q2 | $11.6M | Sell |
212,830
-276,875
| -57% | -$14.9M | 0.01% | 732 |
|
|
2019
Q1 | $26.2M | Buy |
489,705
+377,154
| +335% | +$23.3M | 0.03% | 546 |
|
|
2018
Q4 | $7.37M | Buy |
112,551
+67,569
| +150% | +$5.04M | 0.01% | 817 |
|
|
2018
Q3 | $3.54M | Sell |
44,982
-120,830
| -73% | -$8.64M | ﹤0.01% | 1147 |
|
|
2018
Q2 | $10.7M | Sell |
165,812
-101,489
| -38% | -$6.69M | 0.01% | 765 |
|
|
2018
Q1 | $16.6M | Sell |
267,301
-3,116,249
| -92% | -$224M | 0.02% | 637 |
|
|
2017
Q4 | $245M | Buy |
3,383,550
+1,738,938
| +106% | +$126M | 0.26% | 102 |
|
|
2017
Q3 | $134M | Buy |
1,644,612
+1,151,372
| +233% | +$91.1M | 0.16% | 169 |
|
|
2017
Q2 | $39.7M | Buy |
493,240
+174,060
| +55% | +$13.7M | 0.05% | 442 |
|
|
2017
Q1 | $25.1M | Sell |
319,180
-508,905
| -61% | -$40.6M | 0.03% | 545 |
|
|
2016
Q4 | $65.3M | Buy |
828,085
+229,233
| +38% | +$18.5M | 0.09% | 307 |
|
|
2016
Q3 | $53.3M | Sell |
598,852
-205,538
| -26% | -$19.4M | 0.08% | 334 |
|
|
2016
Q2 | $77M | Sell |
804,390
-578,270
| -42% | -$57.6M | 0.14% | 213 |
|
|
2016
Q1 | $143M | Sell |
1,382,660
-1,231,452
| -47% | -$120M | 0.26% | 102 |
|
|
2015
Q4 | $256M | Sell |
2,614,112
-1,416,654
| -35% | -$139M | 0.45% | 37 |
|
|
2015
Q3 | $389M | Sell |
4,030,766
-771,620
| -16% | -$81.1M | 0.78% | 10 |
|
|
2015
Q2 | $504M | Buy |
4,802,386
+942,476
| +24% | +$96.3M | 1% | 4 |
|
|
2015
Q1 | $398M | Buy |
3,859,910
+35,316
| +0.9% | +$3.57M | 0.91% | 7 |
|
|
2014
Q4 | $368M | Buy |
3,824,594
+682,530
| +22% | +$60.1M | 0.77% | 9 |
|
|
2014
Q3 | $250M | Buy |
3,142,064
+97,088
| +3% | +$7.65M | 0.69% | 13 |
|
|
2014
Q2 | $230M | Sell |
3,044,976
-281,200
| -8% | -$21.3M | 0.62% | 15 |
|
|
2014
Q1 | $249M | Buy |
3,326,176
+609,149
| +22% | +$43M | 0.75% | 9 |
|
|
2013
Q4 | $194M | Sell |
2,717,027
-295,837
| -10% | -$19M | 0.58% | 16 |
|
|
2013
Q3 | $171M | Sell |
3,012,864
-64,477
| -2% | -$3.84M | 0.6% | 17 |
|
|
2013
Q2 | $176M | Buy |
+3,077,341
| New | +$178M | 0.62% | 19 |
|
Other funds holding CVS
VCM
VPM
AQR Capital Management's CVS Position: Q1 2026 in Review
AQR Capital Management reduced its CVS Health (CVS) stake by 8.7% in Q1 2026, selling an estimated $17.5M and leaving 2,387,964 shares worth $170M. The position accounts for 0.08% of the portfolio, ranked #346.
AQR Capital Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $504M in Q2 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- AQR Capital Management held 2,387,964 shares of CVS Health worth $170M as of Q1 2026.
- AQR Capital Management sold 226,994 CVS Health shares in Q1 2026, an estimated $17.5M.
- CVS Health made up 0.08% of AQR Capital Management's portfolio in Q1 2026, its #346 holding.
- AQR Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- AQR Capital Management's CVS Health position peaked at $504M in Q2 2015.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.